TrialJournal of endocrinological investigation2024
Comparative assessment of immunogenicity of recombinant insulin Aspart from BioGenomics and its originator NovoRapid® in adult patients with type 2 diabetes mellitus.
A Mishra et al.PubMed ↗Publisher ↗
No numbers read from the abstract.